Rising Healthcare Investments Accelerate the Adoption of Urinary Incontinence Devices
The global urinary incontinence treatment devices market is witnessing significant growth as the prevalence of urinary incontinence and overactive bladder continues to increase worldwide. The market was valued at approximately US$2.7 billion in 2021 and is projected to expand at a CAGR of 7.7% from 2022 to 2031, reaching more than US$5.5 billion by the end of 2031.
Rising Prevalence Creates Strong Market Opportunities
Urinary incontinence refers to the involuntary leakage of urine caused by a loss of bladder control. The condition affects millions of people globally and becomes increasingly common with age. Women are particularly affected due to factors such as pregnancy, childbirth, menopause, and weakening of the pelvic floor muscles.
Other contributing factors include urinary tract infections, obesity, neurological disorders, and prostate-related conditions. The large patient population and growing awareness about available treatment options are creating sustained demand for urinary incontinence treatment devices.
Technological Advancements Support Market Expansion
Technological innovation is one of the key factors driving the market. Manufacturers are increasingly developing minimally invasive, wearable, non-implantable, and electrical stimulation devices designed to improve bladder control and strengthen pelvic floor muscles.
Electrical stimulation devices represented approximately 42% of the global market in 2021, making them a leading product segment. Their popularity is supported by their effectiveness, growing patient acceptance, and the increasing availability of advanced solutions for conditions such as overactive bladder.
The development of devices that offer convenient and less invasive treatment options is expected to further support market growth during the forecast period.
Prostate Cancer and Surgical Procedures Add to Demand
The increasing incidence of prostate cancer is another important factor influencing demand for urinary incontinence treatment devices. Men undergoing radical prostatectomy may experience urinary incontinence due to changes affecting bladder function, sphincter control, or surrounding nerves.
Post-prostatectomy incontinence can significantly affect quality of life, increasing the need for effective treatment solutions. As the number of prostate cancer procedures rises, demand for devices designed to manage male urinary incontinence is expected to increase.
Get Sample PDF Copy: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=26612
Hospitals Remain Major End Users
Hospitals accounted for around 60% of the market in 2021, supported by the high volume of surgical and treatment procedures performed in hospital settings. Favorable reimbursement policies, particularly in developed markets, also encourage the adoption of medical devices for urinary incontinence.
Meanwhile, growing interest in home-based and non-invasive treatment options could create additional opportunities for manufacturers as patients increasingly seek convenient solutions.
North America Leads the Global Market
North America held approximately 42% of the global market in 2021, supported by advanced healthcare infrastructure, early adoption of medical technologies, a large patient population, and favorable reimbursement policies.
Europe represented around 32% of the market, benefiting from increasing product adoption, technological advancements, and the presence of established medical device manufacturers. Asia Pacific is also expected to offer substantial growth opportunities as healthcare infrastructure improves and awareness of urinary incontinence treatments increases.
Competitive Landscape
Major companies operating in the market include Medtronic, Coloplast Group, B. Braun, Teleflex, Hollister Incorporated, Johnson & Johnson, Promedon Group, Atlantic Therapeutics, and ZSI Surgical Implants. New product launches, regulatory clearances, and investments in innovative treatment technologies are expected to remain important strategies for market participants.
Overall, rising disease prevalence, technological innovation, increasing awareness, and improvements in healthcare access are expected to make the urinary incontinence treatment devices market an attractive area for growth through 2031.
Media Contact:
Abhishek Budholiya
Transparency Market Research Inc.
State Tower, 90 State Street, Suite 700,
Albany NY - 12207, United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
- Art
- Causes
- Crafts
- Dance
- Drinks
- Film
- Fitness
- Food
- Oyunlar
- Gardening
- Health
- Home
- Literature
- Music
- Networking
- Other
- Party
- Religion
- Shopping
- Sports
- Theater
- Wellness